At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
PREREQUISITES
* Bachelors degree with 9 plus years Pharmaceutical/CRO experience as a SAS Programmer supporting clinical trials for regulatory submissions; or 8 plus years experience with a MS/MA degree.
* Bristol-Myers Squibb is a global Biopharma company committed to a single mission: to discover, develop, and deliver innovative medicines focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis.
* Join us and make a difference. We hire the best people and provide them with a work environment that places a premium on diversity, integrity, collaboration and personal development. Through a culture of inclusion, we create a better, more productive work environment. We believe that the diverse experiences and perspectives of all our employees help to drive innovation and transformative business results.
Responsibilities will include, but are not limited to, the following:
* Provide programming input to CRF, SAP, analysis file specifications, and tables, figures, and listings (TFLs) shells.
* Write SAS programs to generate derived analysis datasets, perform analysis, and TFLs.
* Perform ad hoc flexible and rapid programming arising from questions generated from planned analyses and results.
* Ensure consistency and adherence to standards within their therapeutic area.
* Provide input to the design of the clinical trial database for proper data capture and to ensure data quality.
* Create Data Definition Tables (DDT) and converting TFLs to the required format for eSubmission.
* Convert, verify and integrate multiple sources of incoming data for the creation of analysis datasets.
* Provide programming support for the preparation of integrated reports, submissions and post-submission activities.
* Serve as the lead programmer in support of NDAs, sNDAs.
* Contribute to the creation, maintenance, and validation of standards for programming tools, outputs and macros.
* Provide training on departmental SOPs/WPs and standard programs.
* Contribute to the creation of naming conventions and standards for the programming environment.
* Routinely interface with cross-functional team members.
* Influences other functions and represents as DOP technical expertise.
* Represent as internal team leader who decides best course of action.
* Coach and advise junior programmers to identify problems and solutions.
* Oversee the services provided by CROs.
Skills/Knowledge Required:
* Bachelors degree in life science, statistics, mathematics, computer science, or related field is required; Masters degree is preferred.
* 9 plus years Pharmaceutical/CRO experience as a SAS Programmer supporting clinical trials for regulatory submissions with a Bachelors degree; or 8 plus years experience with a MS/MA degree.
* Demonstrated proficiency in using SAS to produce derived analysis datasets and produce TFLs.
* Thorough understanding of clinical data structures, relational database structures, and data exchange with alternate data formats.
* Demonstrated skills in using additional software tools and applications (e.g. MS office, XML).
* Demonstrated expertise in the handling and processing of upstream data, e.g., multiple data forms, workflow, eDC, SDTM.
* Demonstrated expertise in providing outputs to meet downstream requirements, e.g., ADaM, Data Definition Table, e-submission.
* In-depth understanding of regulatory, industry, and technology standards and requirements.
* Good knowledge of statistical terminology, clinical tests, medical terminology, and protocol designs.
* Demonstrated ability to work in a team environment with clinical team members.
* Excellent planning and project management skills.
* Good interpersonal, communication, writing and organizational skills.
* Keep abreast of evolving regulatory, industry, and technology changes and demands, e.g., CDISC, SDTM, ADaM, eDC.
GBDS
GBDSProgramming
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
New York, New York
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.
It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.
The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.